Dr. Jamila Benmoussa, M.D

NPI: 1083054332
Total Payments
$7,756
2024 Payments
$332.52
Companies
30
Transactions
197
Medicare Patients
1,733
Medicare Billing
$245,931

Payment Breakdown by Category

Food & Beverage$4,779 (61.6%)
Travel$2,107 (27.2%)
Consulting$870.00 (11.2%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $4,779 188 61.6%
Travel and Lodging $2,107 8 27.2%
Consulting Fee $870.00 1 11.2%

Top Paying Companies

Company Total Records Latest Year
Medtronic MiniMed, Inc. $2,813 21 $0 (2020)
Novo Nordisk Inc $1,558 34 $0 (2024)
AstraZeneca Pharmaceuticals LP $491.48 11 $0 (2021)
Insulet Corporation $420.24 32 $0 (2022)
Janssen Pharmaceuticals, Inc $313.46 10 $0 (2020)
Amgen Inc. $278.98 10 $0 (2019)
Medtronic, Inc. $278.64 3 $0 (2024)
Lilly USA, LLC $273.48 24 $0 (2020)
DEXCOM, INC. $200.40 6 $0 (2021)
Tandem Diabetes Care, Inc. $149.70 3 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $332.52 4 Medtronic, Inc. ($154.09)
2023 $1,122 6 Novo Nordisk Inc ($903.32)
2022 $83.47 1 Insulet Corporation ($83.47)
2021 $184.64 4 DEXCOM, INC. ($73.85)
2020 $913.43 37 Novo Nordisk Inc ($208.02)
2019 $3,277 116 Medtronic MiniMed, Inc. ($1,655)
2018 $602.39 20 Janssen Pharmaceuticals, Inc ($134.79)
2017 $1,241 9 Medtronic MiniMed, Inc. ($946.97)

All Payment Transactions

197 individual payment records from CMS Open Payments — Page 1 of 8

Date Company Product Nature Form Amount Type
09/24/2024 Xeris Pharmaceuticals, Inc. RECORLEV (Drug) Food and Beverage In-kind items and services $122.88 General
Category: Adrenal steroidogenesis inhibitor
08/07/2024 ABBVIE INC. Food and Beverage In-kind items and services $34.14 General
05/14/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $21.41 General
Category: Diabetes
01/26/2024 Medtronic, Inc. MINIMED 780G (Device) Food and Beverage In-kind items and services $154.09 General
Category: Durable Pump
11/16/2023 Novo Nordisk Inc Consulting Fee Cash or cash equivalent $870.00 General
08/08/2023 Tandem Diabetes Care, Inc. t:slim X2 Insulin Pump with Control-IQ (Device) Food and Beverage In-kind items and services $106.79 General
Category: Endocrinology
07/07/2023 Medtronic, Inc. MINIMED 780G (Device) Food and Beverage In-kind items and services $111.41 General
Category: Durable Pump
06/17/2023 Novo Nordisk Inc Food and Beverage In-kind items and services $18.00 General
02/01/2023 Novo Nordisk Inc Rybelsus (Drug), Ozempic Food and Beverage In-kind items and services $13.01 General
Category: Diabetes
02/01/2023 Novo Nordisk Inc Rybelsus (Drug), Ozempic Food and Beverage In-kind items and services $2.31 General
Category: Diabetes
07/15/2022 Insulet Corporation Omnipod (Device) Food and Beverage Cash or cash equivalent $83.47 General
Category: Insulin Pump
10/01/2021 AstraZeneca Pharmaceuticals LP Food and Beverage In-kind items and services $62.49 General
09/15/2021 DEXCOM, INC. DEXCOM G6 TRANSMITTER (Device) Food and Beverage In-kind items and services $73.85 General
Category: ENDOCRINOLOGY
03/31/2021 Medtronic, Inc. Minimed 670G System (Device) Food and Beverage In-kind items and services $13.14 General
Category: Durable Pump
03/18/2021 Horizon Therapeutics plc TEPEZZA (Drug) Food and Beverage Cash or cash equivalent $35.16 General
Category: TEPEZZA
11/12/2020 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $18.91 General
Category: Cardiovascular and Metabolism
09/21/2020 Novo Nordisk Inc Food and Beverage In-kind items and services $21.75 General
09/09/2020 AstraZeneca Pharmaceuticals LP Food and Beverage In-kind items and services $23.83 General
08/28/2020 Novo Nordisk Inc Ozempic (Drug), RYBELSUS Food and Beverage In-kind items and services $16.67 General
Category: Diabetes
08/27/2020 Novo Nordisk Inc Food and Beverage In-kind items and services $4.64 General
08/25/2020 Insulet Corporation Omnipod (Device) Food and Beverage Cash or cash equivalent $35.52 General
Category: Insulin Pump
08/20/2020 Ultragenyx Pharmaceutical Inc. Food and Beverage In-kind items and services $11.11 General
08/17/2020 Dexcom, Inc. DEXCOM G6 CGM SYSTEM (Device) Food and Beverage In-kind items and services $18.83 General
Category: ENDOCRINOLOGY
08/11/2020 Lilly USA, LLC TRULICITY (Drug), JARDIANCE, TRIJARDY XR Food and Beverage In-kind items and services $14.15 General
Category: Diabetes
07/14/2020 Novo Nordisk Inc Food and Beverage In-kind items and services $2.01 General

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 3 334 716 $148,432 $54,401
2022 3 383 876 $177,007 $65,189
2021 3 418 986 $184,854 $71,018
2020 13 598 908 $148,485 $55,323
Total Patients
1,733
Total Services
3,486
Medicare Billing
$245,931
Procedure Codes
22

All Medicare Procedures & Services

22 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 192 558 $83,700 $34,548 41.3%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 121 127 $57,912 $16,963 29.3%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 21 31 $6,820 $2,890 42.4%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 199 637 $93,670 $35,357 37.7%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 137 146 $63,327 $22,369 35.3%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 47 93 $20,010 $7,464 37.3%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2021 232 770 $109,340 $42,327 38.7%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2021 152 161 $64,239 $24,350 37.9%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2021 34 55 $11,275 $4,341 38.5%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2020 115 326 $46,292 $17,916 38.7%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2020 86 89 $35,511 $13,982 39.4%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 110 157 $32,970 $10,582 32.1%
99443 Physician telephone patient service, 21-30 minutes of medical discussion Office 2020 47 52 $8,215 $4,351 53.0%
99204 New patient office or other outpatient visit, typically 45 minutes Office 2020 20 20 $6,400 $2,234 34.9%
99442 Physician telephone patient service, 11-20 minutes of medical discussion Office 2020 33 35 $4,283 $1,811 42.3%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2020 14 16 $3,280 $1,257 38.3%
99205 New patient office or other outpatient visit, typically 60 minutes Office 2020 13 13 $5,239 $1,152 22.0%
83036 Hemoglobin a1c level Office 2020 59 74 $1,924 $672.48 35.0%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 14 15 $2,130 $597.81 28.1%
95251 Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours Office 2020 12 18 $1,566 $479.82 30.6%
82962 Blood glucose (sugar) test performed by hand-held instrument Office 2020 63 80 $480.00 $249.34 51.9%
36415 Insertion of needle into vein for collection of blood sample Office 2020 12 13 $195.00 $38.76 19.9%

About Dr. Jamila Benmoussa, M.D

Dr. Jamila Benmoussa, M.D is a Student in an Organized Health Care Education/Training Program healthcare provider based in Albany, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/01/2013. The National Provider Identifier (NPI) number assigned to this provider is 1083054332.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jamila Benmoussa, M.D has received a total of $7,756 in payments from pharmaceutical and medical device companies, with $332.52 received in 2024. These payments were reported across 197 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($4,779).

As a Medicare-enrolled provider, Benmoussa has provided services to 1,733 Medicare beneficiaries, totaling 3,486 services with total Medicare billing of $245,931. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.

Practice Information

Products in Payments

  • Minimed 670G System (Device) $2,805
  • Ozempic (Drug) $422.34
  • Omnipod (Device) $420.24
  • FARXIGA (Drug) $388.33
  • INVOKANA (Drug) $272.00
  • MINIMED 780G (Device) $265.50
  • EVENITY (Biological) $160.59
  • RECORLEV (Drug) $122.88
  • Repatha (Biological) $118.39
  • JARDIANCE (Drug) $107.07
  • t:slim X2 Insulin Pump with Control-IQ (Device) $106.79
  • THYROGEN (Drug) $99.79
  • Korlym (Drug) $97.90
  • DEXCOM CGM (Device) $86.38
  • DEXCOM G6 TRANSMITTER (Device) $73.85
  • BAQSIMI (Drug) $70.35
  • AFREZZA (Drug) $69.60
  • JANUVIA (Drug) $62.22
  • Tresiba (Drug) $61.52
  • HUMULIN (Drug) $59.25

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Student in an Organized Health Care Education/Training Program Doctors in Albany